INTRODUCTION
Here we describe a simple and cost-effective PCR-based method to introduce deletions, point mutations, frame-shift, or truncations with very high efficiency. The scope and additional applications of the method are discussed.
Site-directed mutagenesis involves the introduction of mutations at the DNA level to alter the primary amino acid sequence of proteins (1,2). To approach the desired level of reliability in generating mutants, several methods have been described, some of which are technically demanding and/or require special reagents (1) (2) (3) (4) (5) (6) . Megaprimer-based methods for site-directed mutagenesis utilize three oligonucleotide primers (4) or only one mutagenic primer (5) in two rounds of PCR. However, when longer fragments are mutagenized, the efficiency of the methods decreases dramatically and the number of side products increases. Inverse PCR can generate mutations with two primers but solely utilizes plasmid DNA templates (6) . We describe a highly efficient, cost-effective, and reliable method to generate mutations along the entire length of the cDNA. The strategy involves the following steps. (i) Four primers (e.g., Figure 1 , primers #1-#4) amplify the cDNA in the first-round PCR. Primer pairs (#1 and #2) and (#3 and #4) generate the N-and C-terminal PCR products, respectively. Primers #2 and #3 are purchased as 5′ phosphorylated primers. Primers #1 and #4 are unphosphorylated. (ii) T4 DNA ligasemediated joining of the PCR products immediately following the first-round PCR. (iii) Second-round amplification of the ligated product using primers #1 and #4. (iv) Restriction digestion of the PCR product (from step 3) and cloning into any vector of choice. In our case, primer #2 contained the desired mutation (S65L, S65W, or R167Q Figure 1 . Strategy for site-directed mutagenesis.
Step 1. Introduction of a deletion shown as an example. Note that gene-specific primers or alternate primers (T7 or T3 promoter primers) are used to achieve a minimum size of a 114-bp product.
Step 2. Ligation of the PCR products.
Step 3. Amplification of the ligated product to generate cDNA containing the desired mutation.
Step 4. Restriction digestion of the final PCR product and ligation into the expression vector. Digest with restriction enzymes (for primers containing restriction sites) and clone into any expression vector.
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BENCHMARKS for the second-round PCR under the conditions described above. Final PCR products were digested with restriction enzymes and gel-purified using the Zymoclean Gel RNA Recovery Kit™ (Zymo Research, Orange, CA, USA). Fifty nanograms of insert were ligated to compatible sites in 50 ng mammalian expression vector, pEGFP-C1, and transformed into chemically competent bacteria. Pfu DNA polymerase is used to ensure blunt ends and avoid secondsite mutations. Initially, gel-purified PCR products from step 1 were used for ligation (step 2). Subsequently, we found that PCR products could be directly used without removing PCR primers ( Figure 2 ). Moreover, Pfu buffer was found to be compatible with ligase buffer; thus, PCR products can be directly ligated without removing the Pfu buffer. The minimum size of the PCR product amplified was 114 bp (Figure 2, lane 15) . Thus, if mutations close to translation initiation or termination sites are needed, alternate primers complementary to the vector (Figure 1 , T7 or T3 promoter primers) or the untranslated regions (UTRs) of the cDNA can be used to amplify at least a 114-bp PCR product. In the second round of PCR, primers are designed to only amplify the open reading frame (ORF).
Using our method, we cloned a number of mutants (examples shown in Figure 2 ) of the Von HippelLindau (VHL) protein in a single day. The procedure can also be adapted to generate novel fusion proteins containing distinct sequence elements. For example, we generated fusions containing the membrane localization signal of integrin alpha-3 and a reporter [enhanced green fluorescent protein (EGFP)] containing the 3′ UTR of integrin alpha-3 ( Figure 2C ) to study messenger RNA (mRNA) transport and protein localization of the reporter fusion. All the constructs were confirmed by sequencing.
The strategy has several advantages. 
